XML 73 R40.htm IDEA: XBRL DOCUMENT v3.19.1
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Assumptions Used to Estimate Fair Values of Share Options Granted

The following table presents the assumptions used to estimate the fair values of the share options granted in the years presented:

 

 

 

March 2016

 

 

August 2016

 

 

December 2016

 

 

May 2017

 

 

September 2017

 

 

2018

 

Risk-free rate

   of return

 

 

2.8

%

 

 

2.5

%

 

 

3.4

%

 

 

3.2

%

 

 

3.5

%

 

2.7%-3.2%

 

Contractual life

   of option

 

10 years

 

 

10 years

 

 

10 years

 

 

10 years

 

 

10 years

 

 

10 years

 

Expected

   term

 

n/a

 

 

n/a

 

 

n/a

 

 

n/a

 

 

n/a

 

 

6.5 years

 

Estimated

   volatility rate

 

 

70

%

 

 

70

%

 

 

70

%

 

 

70

%

 

 

70

%

 

 

70

%

Expected

   dividend

   yield

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

Fair value of

   underlying

   ordinary

   shares

 

 

7.14

 

 

 

8.04

 

 

 

8.04

 

 

 

9.60

 

 

 

27.93

 

 

17.60-24.58

 

Summary of Option Activity

A summary of option activity under the Plan during the years ended December 31, 2016, 2017 and 2018 is presented below:

 

 

 

Number of

options

 

 

Weighted

average exercise

price

 

 

Weighted

average

remaining

contractual term

 

 

Aggregate

intrinsic value

 

 

 

 

 

 

 

$

 

 

Years

 

 

$

 

Outstanding at January 1, 2016

 

 

4,309,232

 

 

 

0.60

 

 

 

9.68

 

 

 

18,874,438

 

Granted

 

 

2,918,993

 

 

 

1.53

 

 

 

 

 

 

 

Forfeited

 

 

(84

)

 

 

1.74

 

 

 

 

 

 

 

Outstanding at December 31, 2016

 

 

7,228,141

 

 

 

0.97

 

 

 

9.00

 

 

 

53,677,170

 

Granted

 

 

264,480

 

 

 

8.76

 

 

 

 

 

 

 

Exercised

 

 

(100,834

)

 

 

0.65

 

 

 

 

 

 

 

Forfeited

 

 

(843,410

)

 

 

1.11

 

 

 

 

 

 

 

Outstanding at December 31, 2017

 

 

6,548,377

 

 

 

1.28

 

 

 

8.06

 

 

 

130,668,851

 

Granted

 

 

2,759,750

 

 

 

21.15

 

 

 

 

 

 

 

Exercised

 

 

(256,065

)

 

 

0.76

 

 

 

 

 

 

 

Forfeited

 

 

(290,327

)

 

 

3.73

 

 

 

 

 

 

 

Outstanding at December 31, 2018

 

 

8,761,735

 

 

 

7.47

 

 

 

7.80

 

 

 

138,009,758

 

Vested and Exercisable as of

    December 31, 2018

 

 

3,321,376

 

 

 

1.01

 

 

 

6.93

 

 

 

73,775,871

 

Vested or expected to vest as of

    December 31, 2018

 

 

8,761,735

 

 

 

7.47

 

 

 

7.80

 

 

 

138,009,758

 

Allocation of Compensation Expense Related to Option

The weighted-average grant-date fair value of the options granted in 2016, 2017 and 2018 were $6.94, $13.92 and $14.03 per share, respectively. The Group recorded compensation expense related to the options of $3,524,733, $4,751,933 and $9,403,059 for the year ended December 31, 2016, 2017 and 2018, respectively, which were classified in the accompanying consolidated statements of operations as follows:

 

 

Year ended December 31,

 

 

 

2016

 

 

2017

 

 

2018

 

 

 

$

 

 

$

 

 

$

 

Selling, general and administrative

 

 

1,472,993

 

 

 

2,215,282

 

 

 

4,428,266

 

Research and development

 

 

2,051,740

 

 

 

2,536,651

 

 

 

4,974,793

 

Total

 

 

3,524,733

 

 

 

4,751,933

 

 

 

9,403,059

 

 

Allocation of Compensation Expense Related to Restricted Shares As of December 31, 2018, there was $14,386,103 of total unrecognized compensation expense related to non-vested restricted shares. The Group recorded compensation expense related to the restricted shares of $1,400,545, $5,179,173 and $2,826,584 for the year ended December 31, 2016, 2017 and 2018, respectively, which were classified in the accompanying consolidated statements of operations as follows:

 

 

Year ended December 31,

 

 

 

2016

 

 

2017

 

 

2018

 

 

 

$

 

 

$

 

 

$

 

Selling, general and administrative

 

 

825,822

 

 

 

3,848,165

 

 

 

2,206,046

 

Research and development

 

 

574,723

 

 

 

1,331,008

 

 

 

620,538

 

Total

 

 

1,400,545

 

 

 

5,179,173

 

 

 

2,826,584